Found: 3
Select item for more details and to access through your institution.
Primary tumour category, site of metastasis, and baseline serum S100B and LDH are independent prognostic factors for survival in metastatic melanoma patients treated with anti-PD-1.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1237643
- By:
- Publication type:
- Article
Combining Biomarkers for the Diagnosis of Metastatic Melanoma.
- Published in:
- Journal of Clinical Medicine, 2024, v. 13, n. 1, p. 174, doi. 10.3390/jcm13010174
- By:
- Publication type:
- Article
Prognostic Role of Clinicopathological Characteristics and Serum Markers in Metastatic Melanoma Patients Treated with BRAF and MEK Inhibitors.
- Published in:
- Cancers, 2024, v. 16, n. 17, p. 2981, doi. 10.3390/cancers16172981
- By:
- Publication type:
- Article